The essential host genome for Cryptosporidium survival exposes metabolic dependencies that can be leveraged for treatment
More about Open Access at the CrickAuthors list
Bishara Marzook Ok-Ryul Song Lotta Baumgärtel Netanya Bernitz Tapoka Mkandawire Lucy Watson Vanessa Nunes Scott Warchal James MacRae Michael Howell Adam SaterialeAbstract
Cryptosporidium is a leading cause of diarrheal disease, yet little is known regarding the infection cell biology of this intracellular intestinal parasite. To this end, we implemented an arrayed genome-wide CRISPR-Cas9 knockout screen to microscopically analyze multiple phenotypic features of a Cryptosporidium infection following individual host gene ablation. We discovered parasite survival within the host epithelial cell hinges on squalene, an intermediate metabolite in the host cholesterol biosynthesis pathway. A buildup of squalene within intestinal epithelial cells creates a reducing environment, making more reduced glutathione available for parasite uptake. Remarkably, the Cryptosporidium parasite has lost the ability to synthesize glutathione and has become dependent on this host import. This dependency can be leveraged for treatment with the abandoned drug lapaquistat, an inhibitor of host squalene synthase that shifts the redox environment, blocking Cryptosporidium growth in vitro and in vivo.
Journal details
Journal
Cell
Volume
188
Issue number
21
Pages
5947-5961 .e15
Available online
Publication date
Full text links
Publisher website (DOI)
10.1016/j.cell.2025.07.001
Figshare
View on figshare
Europe PubMed Central
40706591
Pubmed
40706591
Keywords
Related topics
Type of publication
Publishing history
The publication was previously a preprint.
View preprint
